Margaret C Wardle1, Harriet de Wit. 1. Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, 1941 East Rd., BBSB 1st Floor, Houston, TX, 77054, USA, Margaret.C.Wardle@uth.tmc.edu.
Abstract
BACKGROUND:±3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") produces "prosocial" effects, such as feelings of empathy and closeness, thought to be important to its abuse and its value in psychotherapy. However, it is not fully understood how MDMA alters basic emotional processes to produce these effects, or whether it produces corresponding changes in actual social behavior. Here, we examined how MDMA affects perceptions of and responses to emotional expressions, and tested its effects on behavior during a social interaction. We also examined whether MDMA's prosocial effects related to a measure of abuse liability. METHODS: Over three sessions, 36 healthy volunteers with previous ecstasy use receivedMDMA (0.75, 1.5 mg/kg) and placebo under double-blind conditions. We measured (i) mood and cardiovascular effects, (ii) perception of and psychophysiological responses to emotional expressions, (iii) use of positive and negative words in a social interaction, and (iv) perceptions of an interaction partner. We then tested whether these effects predicted desire to take the drug again. RESULTS:MDMA slowed perception of angry expressions, increased psychophysiological responses to happy expressions, and increased positive word use and perceptions of partner empathy and regard in a social interaction. These effects were not strongly related to desire to take the drug again. CONCLUSIONS:MDMA alters basic emotional processes by slowing identification of negative emotions and increasing responses to positive emotions in others. Further, it positively affects behavior and perceptions during actual social interaction. These effects may contribute to the efficacy of MDMA in psychotherapy, but appear less closely related to its abuse potential.
RCT Entities:
BACKGROUND: ±3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") produces "prosocial" effects, such as feelings of empathy and closeness, thought to be important to its abuse and its value in psychotherapy. However, it is not fully understood how MDMA alters basic emotional processes to produce these effects, or whether it produces corresponding changes in actual social behavior. Here, we examined how MDMA affects perceptions of and responses to emotional expressions, and tested its effects on behavior during a social interaction. We also examined whether MDMA's prosocial effects related to a measure of abuse liability. METHODS: Over three sessions, 36 healthy volunteers with previous ecstasy use received MDMA (0.75, 1.5 mg/kg) and placebo under double-blind conditions. We measured (i) mood and cardiovascular effects, (ii) perception of and psychophysiological responses to emotional expressions, (iii) use of positive and negative words in a social interaction, and (iv) perceptions of an interaction partner. We then tested whether these effects predicted desire to take the drug again. RESULTS:MDMA slowed perception of angry expressions, increased psychophysiological responses to happy expressions, and increased positive word use and perceptions of partner empathy and regard in a social interaction. These effects were not strongly related to desire to take the drug again. CONCLUSIONS:MDMA alters basic emotional processes by slowing identification of negative emotions and increasing responses to positive emotions in others. Further, it positively affects behavior and perceptions during actual social interaction. These effects may contribute to the efficacy of MDMA in psychotherapy, but appear less closely related to its abuse potential.
Authors: Christopher P Benton; Peter J Etchells; Gillian Porter; Andrew P Clark; Ian S Penton-Voak; Stavri G Nikolov Journal: Proc Biol Sci Date: 2007-09-07 Impact factor: 5.349
Authors: Nora T Walter; Smiljana Mutic; Sebastian Markett; Christian Montag; Alisa M Klein; Martin Reuter Journal: Alcohol Alcohol Date: 2011-07-12 Impact factor: 2.826
Authors: Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Rick Doblin Journal: J Psychopharmacol Date: 2010-07-19 Impact factor: 4.153
Authors: Anya K Bershad; Jessica J Weafer; Matthew G Kirkpatrick; Margaret C Wardle; Melissa A Miller; Harriet de Wit Journal: Soc Neurosci Date: 2016-02-17 Impact factor: 2.083